Write your message
Volume 16, Issue 4 (October 2022)                   IJT 2022, 16(4): 237-246 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nurfadilah N, Djabir Y Y, Aminah S, Patimang Y C, Santoso A, Yulianty R. Black Seed Oil Protects Against Levofloxacin Hepatotoxicity: Analyses of the Biochemical and Histopathological Effects. IJT 2022; 16 (4) :237-246
URL: http://ijt.arakmu.ac.ir/article-1-1130-en.html
1- Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia.
2- Laboratory of Clinical Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia. , yulia.yusrini@unhas.ac.id
3- Laboratory of Clinical Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia.
4- Department of Pulmonology, Faculty of Medicine, Hasanuddin University, Indonesia, Makassar.
5- Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia.
Abstract:   (387 Views)
Background: Long-term use of levofloxacin can cause alterations in the liver function. This study aimed to determine the protective effect of black seed oil (BSO) against liver injury due to levofloxacin administration in rats.
Methods: The chemical composition of BSO was analyzed with gas chromatography and mass spectrophotometry (GC-MS). Rats (n=30) were treated daily with levofloxacin and BSO at three doses (1, 2 or 4 mL/kg) orally for 28 days. The presence of liver injury was determined based on serum biomarkers and liver malondialdehyde (MDA) levels, and histopathological examinations. 
Results: The GC-MS analyses showed that BSO contained 25 chemical compounds, including thymoquinone (10.14%). The levofloxacin administration significantly increased the liver enzymes and MDA levels, and induced a marked alteration in the liver histological structures. Treatments of rats with one or two mL/kg BSO significantly decreased the liver enzymes, and MDA levels compared to those that received levofloxacin alone (P<0.05). However, the highest dose (4 mL/kg) BSO failed to improve liver MDA levels. The recovery of liver histological damages was also observed in rats treated with BSO. 
Conclusion: It was concluded that the BSO administration reduced the liver dysfunction due to levofloxacin at doses of 1 or 2 mL/kg, but not at 4 mL/kg. Further research is warranted to explore if the protective effect of BSO is associated with its antioxidant properties.
 
Full-Text [PDF 1088 kb]   (195 Downloads) |   |   Full-Text (HTML)  (22 Views)  
Type of Study: Research | Subject: General

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb